Cargando…

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer

Novel approaches for classification, including molecular features, are needed to direct therapy for men with low-grade prostate cancer (PCa), especially men on active surveillance. Risk alleles identified from genome-wide association studies (GWAS) could improve prognostication. Those risk alleles t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowinski, Salpie, Santaolalla, Aida, O’Leary, Ben, Loda, Massimo, Mirchandani, Ayesha, Emberton, Mark, Van Hemelrijck, Mieke, Grigoriadis, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849176/ https://www.ncbi.nlm.nih.gov/pubmed/29560112 http://dx.doi.org/10.18632/oncotarget.24400

Ejemplares similares

Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases
por: De Piano, Mario, et al.
Publicado: (2020)

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
por: Santaolalla, Aida, et al.
Publicado: (2019)

Serum Lipid Profiles and Cancer Risk in the Context of Obesity: Four Meta-Analyses
por: Melvin, Jennifer C., et al.
Publicado: (2013)

The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
por: Santaolalla, Aida, et al.
Publicado: (2021)

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
por: Santaolalla, Aida, et al.
Publicado: (2020)

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression
por: Shah, Vandna, et al.
Publicado: (2017)

Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
por: Russell, Beth, et al.
Publicado: (2020)

Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer
por: Murphy, Keefe, et al.
Publicado: (2018)

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
por: Adams, Daniel L., et al.
Publicado: (2016)

Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study
por: Bosco, Cecilia, et al.
Publicado: (2015)

Serum glucose and risk of cancer: a meta-analysis
por: Crawley, Danielle J, et al.
Publicado: (2014)

Antibodies as biomarkers for cancer risk: a systematic review
por: Monroy-Iglesias, Maria J, et al.
Publicado: (2022)

Identifying consistent allele frequency differences in studies of stratified populations
por: Wiberg, R. Axel W., et al.
Publicado: (2017)

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2017)

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Prevalence, Gender and Age Differences of Dating Aggression Among Italian Adolescents
por: Cuccì, Gaia, et al.
Publicado: (2020)

Variations in Aggressive and Indolent Behaviour of Central Dentinogenic Ghost Cell Tumor
por: Bavle, Radhika Manoj, et al.
Publicado: (2020)

Automated detection of aggressive and indolent prostate cancer on magnetic resonance imaging
por: Seetharaman, Arun, et al.
Publicado: (2021)

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
por: Santaolalla, Aida, et al.
Publicado: (2021)

Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2022)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2021)

A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior
por: Shi, Min, et al.
Publicado: (2015)

Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers
por: Mamidi, Tarun Karthik Kumar, et al.
Publicado: (2019)

Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis
por: Cantù, Giulio
Publicado: (2021)

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms
por: Fernández-Garnacho, Elena María, et al.
Publicado: (2023)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes
por: Paudel, B. Bishal, et al.
Publicado: (2023)

Raman Spectroscopy of Liquid-Based Cervical Smear Samples as a Triage to Stratify Women Who Are HPV-Positive on Screening
por: Traynor, Damien, et al.
Publicado: (2021)

Differentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value
por: Lee, Elaine Yuen Phin, et al.
Publicado: (2013)

Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells
por: Saurty-Seerunghen, Mirca S., et al.
Publicado: (2019)

Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis
por: Cantù, Giulio
Publicado: (2021)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
por: Marsden, Teresa, et al.
Publicado: (2021)

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021)

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?
por: Ji, Guangjie, et al.
Publicado: (2017)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling
por: Gilgunn, Sarah, et al.
Publicado: (2020)

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
por: Moore, J. L., et al.
Publicado: (2022)

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
por: Sollie, Sam, et al.
Publicado: (2019)

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
por: Sollie, Sam, et al.
Publicado: (2020)

Can laboratory blood tests be used to risk stratify patients admitted with pneumonia?
por: Apps, L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fg6sn847bvlrqdkh00vste3cb2